XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Schedule of Stock Option Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 3 years  
Number of Options, Forfeited (13,333)  
Number of Options, Outstanding Ending 148,905  
Number of Options, Forfeited/Cancelled 13,333  
Employees And Consultants [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Granted 21,167  
Employees And Consultants [Member] | Non-Qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 158,174  
Weighted Average Exercise Price, Outstanding Beginning $ 10.99  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 7 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted 21,167  
Weighted Average Exercise Price, Granted $ 3.55  
Weighted Average Remaining Contractual Term, Granted 9 years 9 months 18 days  
Aggregate Intrinsic Value, Exercised $ 4,650  
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Remaining Contractual Term,Exercised  
Number of Options, Forfeited (13,333)  
Weighted Average Exercise Price, Forfeited/Cancelled $ 9.15  
Weighted Average Remaining Contractual Term,Forfeited 0 years  
Number of Options, Expired  
Weighted Average Exercise Price, Expired  
Weighted Average Remaining Contractual Term,Expired  
Number of Options, Outstanding Ending 166,007  
Weighted Average Exercise Price, Outstanding Ending $ 10.18  
Weighted Average Remaining Contractual Term, Outstanding Ending 8 years 2 months 12 days  
Aggregate Intrinsic Value, Outstanding Ending $ 4,650  
Number of Options, Exercisable Ending 118,828  
Weighted Average Exercise Price, Exercisable Ending $ 11.89  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 7 years 7 months 6 days  
Aggregate Intrinsic Value, Exercisable Ending $ 610  
Number of Options, Forfeited/Cancelled 13,333  
Directors [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Granted 6,250  
Directors [Member] | Non-Qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding Beginning 50,872  
Weighted Average Exercise Price, Outstanding Beginning $ 10.02  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 6 years 7 months 6 days  
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted 6,250  
Weighted Average Exercise Price, Granted $ 4.80  
Weighted Average Remaining Contractual Term, Granted 9 years 9 months 18 days  
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Number of Options, Forfeited  
Weighted Average Exercise Price, Forfeited/Cancelled  
Number of Options, Expired  
Weighted Average Exercise Price, Expired  
Number of Options, Outstanding Ending 57,122  
Weighted Average Exercise Price, Outstanding Ending $ 9.44  
Weighted Average Remaining Contractual Term, Outstanding Ending 6 years 8 months 12 days  
Aggregate Intrinsic Value, Outstanding Ending  
Number of Options, Exercisable Ending 57,122  
Weighted Average Exercise Price, Exercisable Ending $ 9.44  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 6 years 8 months 12 days  
Aggregate Intrinsic Value, Exercisable Ending  
Number of Options, Forfeited/Cancelled  
Directors [Member] | Non-Qualified Stock Options [Member] | 2017 Equity Incentive Plan [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted Average Remaining Contractual Term,Expired